ValueAct Buys 3M Valeant Pharma (VRX) Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Valeant Pharma (VRX) Director De Schutter Buys 10K Shares
March 16, 2017 5:17 PM EDTValeant Pharma (NYSE: VRX) Director, Richard De Schutter, bought 10,000 shares on 03/15 at $10.80
... MoreValeant Pharma (VRX) CFO Buys 24K Shares
March 16, 2017 5:09 PM EDTValeant Pharma (NYSE: VRX) CFO Paul Herendeen disclosed buying 24,000 shares on 03/14 at $10.72, bringing his stake to 174,000 shares.
The disclosure from Herendeen follows the 3 million share purchase from large and noted investor group ValueAct capital.
FORM... More



